Effects of lovastatin therapy on guinea pig low density lipoprotein composition and metabolism.
Lovastatin therapy is known to induce hepatic low density lipoprotein (LDL) receptor mRNA and LDL receptor activity. Yet, in studies in humans and animals it has been difficult to demonstrate an enhancement of the plasma fractional catabolic rate (FCR) of an injected LDL tracer during lovastatin the...
Main Authors: | L Berglund, M F Sharkey, R L Elam, J L Witztum |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1989-10-01
|
Series: | Journal of Lipid Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520382420 |
Similar Items
-
Altered apolipoprotein B metabolism in very low density lipoprotein from lovastatin-treated guinea pigs.
by: L F Berglund, et al.
Published: (1994-06-01) -
"EFFECT OF PROGESTERONE AND LOVASTATIN ON THE SECRETION OF VERY LOW DENSITY LIPOPROTEIN 1 AND 2 IN THE NORMAL GUINEA PIG MODEL"
by: F. Asadi Jamnani, et al.
Published: (2004-10-01) -
Guinea pig low density lipoproteins: structural and metabolic heterogeneity
by: G Luc, et al.
Published: (1988-10-01) -
Lovastatin enhances hepatic uptake of low density lipoprotein in humans.
by: K Kervinen, et al.
Published: (1993-11-01) -
Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach
by: Lars Berglund, et al.
Published: (1998-04-01)